ACS Nano · 2019 · 420 citations · 70 references
MedicineNeurobiologyNeuroscienceCellular NeuroscienceMolecular NeuroscienceRegenerative MedicineMesenchymal Stem Cell TherapyNerve RegenerationNeural RegenerationNeuroinflammationNeuroprotectionSpinal Cord InjuryBlood-brain Barrier TraffickingExosome-based TherapyExosomesIntranasal AdministrationIntranasal FormulationsSpinal Cord Injury RecoverySpinal Cord Injury RepairSpinal Cord Repair
Individuals with spinal cord injury (SCI) usually suffer from permanent neurological deficits, while spontaneous recovery and therapeutic efficacy are limited. Here, we demonstrate that when given intranasally, exosomes derived from mesenchymal stem cells (MSC-Exo) could pass the blood brain barrier and migrate to the injured spinal cord area. Furthermore, MSC-Exo loaded with phosphatase and tensin homolog small interfering RNA (ExoPTEN) could attenuate the expression of PTEN in the injured spinal cord region following intranasal administrations. In addition, the loaded MSC-Exo considerably enhanced axonal growth and neovascularization, while reducing microgliosis and astrogliosis. The intranasal ExoPTEN therapy could also partly improve structural and electrophysiological function and, most importantly, significantly elicited functional recovery in rats with complete SCI. The results imply that intranasal ExoPTEN may be used clinically to promote recovery for SCI individuals.
70
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez‐Erviti, Yiqi Seow, HaiFang Yin et al. · Nature Biotechnology · 2011 · 4.8K citations
Chondroitinase ABC promotes functional recovery after spinal cord injury
Elizabeth J. Bradbury, Lawrence Moon, Reena J. Popat et al. · Nature · 2002 · 2.3K citations
Medicine, Neurobiology, Neuroscience +16
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Matthew J. Haney, Natalia L. Klyachko, Yuling Zhao et al. · Journal of Controlled Release · 2015 · 2K citations · Full text